Hematopoietic stem cell transplant-related airflow obstruction

Current Opinion in Oncology

Volumn 18, Issue 2, 2006, Pages 115-119

  Dudek, Arkadiusz Z ^a,b   Mahaseth, ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MMC 480 ^*  (United States)

Author keywords

Airflow obstruction; Bronchiolitis obliterans; Graft versus host disease; Hematopoietic stem cell transplantation

Indexed keywords

AZATHIOPRINE; AZITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISONE; THALIDOMIDE; THYMOCYTE ANTIBODY;

AIRWAY OBSTRUCTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; BRONCHIOLITIS OBLITERANS; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEART LUNG TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; PRIORITY JOURNAL; REVIEW;

AIRWAY OBSTRUCTION; BRONCHIOLITIS OBLITERANS; CLINICAL TRIALS; GRAFT VS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; RISK FACTORS;

EID: 33646679825     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cco.0000208782.61452.08     Document Type: Review

References (33)

1. Milojkovic D, Mufti GJ. Extending the role of allogeneic stem-cell transplantation. Lancet 2001; 357:652-654.
2. Traynor AE, Schroeder J, Rosa RM, et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 2000; 356:701-707.
3. Bryant DH. Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated? Eur Respir J 2005; 25:402-404.
4. Chan CK, Hyland RH, Hutcheon MA. Pulmonary complications following bone marrow transplantation. Clin Chest Med 1990; 11:323-332.
5. Krowka MJ, Rosenow EC 3rd, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 1985; 87:237-246.
6. Roca J, Granena A, Rodriguez-Roisin R, et al. Fatal airway disease in an adult with chronic graft-versus-host disease. Thorax 1982; 37:77-78.
7. Rosenberg ME, Vercellotti GM, Snover DC, et al. Bronchiolitis obliterans after bone marrow transplantation. Am J Hematol 1985; 18:325-328.
8. Clark JG, Schwartz DA, Flournoy N, et al. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 107:648-656.
9. Holland HK, Wingard JR, Beschorner WE, et al. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988; 72:621-627.
10. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation: clinical presentation and course. Ann Intern Med 1989; 111:368-376.
11. Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003; 9:657-666.
12. Santo Tomas LH, Loberiza FR Jr, Klein JP, et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005; 128:153-161. Identifies new risk factors for bronchiolitis obliterans in allogeneic HSCT for leukemia, including peripheral blood stem cell transplantation, long duration to transplant, female donor to male recipient, and prior episode of interstitial pneumonitis.
13. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002; 166:440-444.
14. Yoshihara S, Tateishi U, Ando T, et al. Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant 2005; 35:1195-1200. Tissue damage secondary to intensive chemoradiotherapy may contribute to the pathogenesis of bronchiolitis obliterans.
15. Jung JI, Jung WS, Hahn ST, et al. Bronchiolitis obliterans after allogenic bone marrow transplantation: HRCT findings. Korean J Radiol 2004; 5:107-113.
16. Pechet TV, de le Morena M, Mendeloff EN, et al. Lung transplantation in children following treatment for malignancy. J Heart Lung Transplant 2003; 22:154-160.
17. Ratjen F, Rjabko O, Kremens B. High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplant 2005; 36:135-138. High-dose pulse methylprednisolone therapy improved pulmonary function in pediatric patients in whom bronchiolitis obliterans was diagnosed after HSCT.
18. Khalid M, Al Saghir A, Saleemi S, et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J 2005; 25:490-493. Azithromycin improved lung function in patients with bronchiolitis obliterans after bone marrow transplant.
19. Patriarca F, Skert C, Sperotto A, et al. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant 2004; 33:751-758.
20. Chien JW, Martin PJ, Flowers ME, et al. Implications of early airflow decline after myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2004; 33:759-764.
21. Marras TK, Chan CK, Lipton JH, et al. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 2004; 33:509-517.
22. Sakaida E, Nakaseko C, Harima A, et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood 2003; 102:4236-4242.
23. Chien JW, Martin PJ, Gooley TA, et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168:208-214.
24. Paz HL, Crilley P, Patchefsky A, et al. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992; 101:775-778.
25. Frankovich J, Donaldson SS, Lee Y, et al. High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes. Biol Blood Marrow Transplant 2001; 7:49-57.
26. O'Brien KD, Hackman RC, Sale GE, et al. Lymphocytic bronchitis unrelated to acute graft-versus-host disease in canine marrow graft recipients. Transplantation 1984; 37:233-238.
27. Crawford SW, Clark JG. Bronchiolitis associated with bone marrow transplantation. Clin Chest Med 1993; 14:741-749.
28. Taylor PM, Rose ML, Yacoub MH. Expression of MHC antigens in normal human lungs and transplanted lungs with obliterative bronchiolitis. Transplantation 1989; 48:506-510.
29. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21:297-310.
30. Sano Y, Date H, Nagahiro I, et al. Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation. Ann Thorac Surg 2005; 79:1051-1052.
31. Boehler A, Chamberlain D, Kesten S, et al. Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation 1997; 64:311-317.
32. Konishi K, Inobe M, Yamada A, et al. Combination treatment with FTY720and CTLA4IgG preserves the respiratory epithelium and prevents obliterative disease in a murine airway model. J Heart Lung Transplant 2002; 21:692-700.
33. Chan A, Allen R. Bronchiolitis obliterans: an update. Curr Opin Pulm Med 2004; 10:133-141.